Evolent Health EVH
NYSE EVH
$4.18 +0.03 (+0.60%)
As of: Sep 10, 2026 · 3:59 PM EDT

Evolent Health (EVH) Long-Term Debt Issuances (2019 - 2026)

Evolent Health (EVH) posted Long-Term Debt Issuances of $10.0 million for Q2 2026, down 84.0% on a QoQ basis from $62.5 million in Q1 2025.

Analysis

Evolent Health (EVH) Long-Term Debt Issuances (2019 - 2026) Analysis & Trends

Evolent Health has reported Long-Term Debt Issuances for 6 years, with the latest figure at $10.0 million in Q2 2026.

  • On a quarterly basis, Long-Term Debt Issuances changed N/A year-over-year to $10.0 million in Q2 2026; TTM through Jun 2026 was $72.5 million, a 73.21% decrease from a year earlier, with the FY2025 full-year figure at $343.0 million, changed N/A from the prior year.
  • Long-Term Debt Issuances was $10.0 million for Q2 2026 at Evolent Health, down from $62.5 million in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $256.3 million in Q1 2023, with the low at -$267000.0 in Q2 2023.
  • Average Long-Term Debt Issuances over 4 years is $126.1 million, with a median of $135.3 million recorded in 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Davita 11.74 Bn 11.05 Bn 1.16 Bn 1.51 Bn
2 RadNet 5.78 Bn 5.06 Bn 88.08 Mn 243.69 Mn
3 Fresenius Medical Care AG 4.79 Bn 4.09 Bn 1.52 Bn 121.81 Mn
4 Concentra Group Holdings Parent 4.28 Bn 4.12 Bn 192.10 Mn -
5 Privia Health 2.57 Bn 2.16 Bn - -
6 Progyny 2.12 Bn 1.88 Bn 89.30 Mn -
7 Pediatrix Medical 2.12 Bn 1.71 Bn - -
8 Surgery Partners 1.82 Bn 1.60 Bn 622.10 Mn 154.60 Mn
9 U S Physical Therapy 1.17 Bn 1.15 Bn 41.94 Mn 45.05 Mn
10 Evolent Health 468.74 Mn 327.27 Mn 80.84 Mn 10.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.00 Mn
Mar 31, 2025 62.50 Mn
Dec 31, 2023 208.14 Mn
Jun 30, 2023 -267,000.00
Mar 31, 2023 256.33 Mn
Sep 30, 2022 219.74 Mn
Dec 31, 2021 -98.42 Mn
Mar 31, 2021 98.42 Mn
Dec 31, 2019 62.65 Mn